Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine

International Journal of Pharmaceutics

Volumn 355, Issue 1-2, 2008, Pages 81-86

  Dalpiaz, A ^a   Mezzena, M ^a   Scatturin, A ^a   Scalia, S ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Controlled release; N6 Cyclopentyladenosine; Polar drug encapsulation; Solid lipid microparticles; Stability in blood; Stearic acid

Indexed keywords

6 N CYCLOPENTYLADENOSINE; GLYCEROL BEHENATE; NITROGEN; PHOSPHATIDYLCHOLINE; SOLID LIPID NANOPARTICLE; STEARIC ACID; SURFACTANT; TRISTEARIN;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG STABILITY; EMULSION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGENATION; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ADENOSINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; LIPOSOMES; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; X-RAY DIFFRACTION;

EID: 41349096444     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.11.044     Document Type: Article

References (31)

1. Bloomfield V.A., Crothers D.M., and Tinocco I.J. Nucleic Acids-Structures, Properties, and Functions (2000), University Science Book, Sausalito, CA
2. Bodmeier R., Wang J., and Bhagwatwar H. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique.II. W/O/W multiple emulsion technique for water-soluble drugs. J. Microencapsul. 9 (1992) 99-107
3. Brodie M.S., Lee K., Fredholm B.B., Stahle L., and Dunwiddie T.V. Central versus peripheral mediation of responses to receptor agonists: evidence against a central mode of action. Brain Res. 415 (1987) 323-330
4. Cook R.O., Pannu R.K., and Kellaway I.W. Novel sustained release microspheres for pulmunary drug delivery. J. Control. Release 104 (2005) 79-70
5. Cortesi R., Esposito E., Luca G., and Nastruzzi C. Production of lipospheres as carriers for bioactive compounds. Biomaterials 23 (2002) 2283-2294
6. 1 receptor agonist. J. Control. Release 73 (2001) 303-313
7. 1 receptor agonist. Pharm. Res. 18 (2001) 531-536
8. 1 receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system. Curr. Med. Chem. 9 (2002) 1923-1927
9. Dalpiaz A., Scatturin A., Pavan B., Biondi C., Vandelli M.A., and Forni F. Poly(lactic acid) microspheres for the sustained release of antiischemic agents. Int. J. Pharm. 242 (2002) 115-120
10. Dalpiaz A., Leo E., Vitali F., Pavan B., Scatturin A., Bortolotti F., Manfredini S., Durini E., Forni F., Brina B., and Vandelli M.A. Development and characterization of biodegradable nanoparticles as delivery systems of antiischemic adenosine derivatives. Biomaterials 26 (2005) 1299-1306
11. Heurteaux C., Lauritzen I., Widmann C., and Lazdunski M. Essential role of adenosine, adenosine A receptors, and ATP-sensitive K channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4666-4670
12. Illum L. Nasal drug delivery-possibilities, problems and solutions. J. Control. Release 87 (2003) 187-198
13. Illum L. Is nose-to-brain transport of drugs in man a reality. J. Pharm. Pharmacol. 56 (2004) 3-17
14. Jacobson K.A., Trivedi B.K., Churchill P.C., and Williams M. Novel therapeutics acting via purinergic receptors. Biochem. Pharmacol. 41 (1991) 1399-1410
15. Jaspart S., Piel G., Delattre L., and Evrard B. Solid lipid microparticles: formulation, preparation, characterization, drug release and applications. Expert Opin. Drug. Deliv. 2 (2005) 75-87
16. Jaspart S., Bertholet P., Piel G., Dogné J.G., Delattre L., and Evrard B. Solid lipid microparticles as a sustained release system for pulmunary drug delivery. Eur. J. Pharm. Biopharm. 65 (2007) 47-56
17. Leo E., Contado C., Bortolotti F., Pavan B., Scatturin A., Tosi G., Manfredini S., Angusti A., and Dalpiaz A. Nanoparticle formulation may affect the stabilization of an antiischemic prodrug. Int. J. Pharm. 307 (2006) 103-113
18. Leo E., Scatturin A., Vighi E., and Dalpiaz A. Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight. J. Nanosci. Nanotech. 6 (2006) 3070-3079
19. 1 antagonist 8-cyclopentyltheophylline and its application in a pharmacokinetic study in rats. J. Chromatogr. 620 (1993) 113-120
20. 6-cyclopentyladenosine (CPA) in the rat. J. Pharmacol. Exp. Ther. 268 (1994) 616-624
21. Pavan B., and Ijzerman A.P. Processing of adenosine receptor agonists in rat and human whole blood. Biochem. Pharmacol. 56 (1998) 1625-1632
22. Ritger P.L., and Peppas N.A. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release 5 (1987) 23-36
23. Scalia S., Simeoni S., Dalpiaz A., and Villani S. Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC. J. Pharm. Biomed. Anal. 24 (2001) 1131-1136
24. Scalia S., Tursilli R., Sala N., and Iannuccelli V. Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 320 (2006) 79-85
25. 1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents. Eur. J. Pharm. Sci. 24 (2005) 59-66
26. Sun L.L., Xu L.L., Nielsen T.B., Rhee P., and Burris D. Cyclopentyladenosine inproves cell proliferation, wound healing and hair growth. J. Surg. Res. 87 (1999) 14-24
27. Tucker A.L., and Linde J. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc. Res. 27 (1993) 54-61
28. Trotta M., Cavalli R., Carlotti M.E., Battaglia L., and Debernardi F. Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique. Int. J. Pharm. 288 (2005) 281-288
29. Tursilli R., Piel G., Delattre L., and Scalia S. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. Eur. J. Pharm. Biopharm. 66 (2007) 483-487
30. Vyas T.K., Shalhiwala A., Marathe S., and Misra a. Intranasal drug delivery for brain targeting. Curr. Drug Deliv. 2 (2005) 165-175
31. Yener G., Incegül T., and Yener N. Importance of using solid lipid microspheres as carriers for UV filters on the example of octyl methoxy cinnamate. Int. J. Pharm. 258 (2003) 203-207